These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29466437)

  • 1. Correction: Metabolomics based predictive biomarker model of ARDS: A systemic measure of clinical hypoxemia.
    PLOS ONE Staff
    PLoS One; 2018; 13(2):e0193474. PubMed ID: 29466437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction: pFAK-Y397 overexpression as both a prognostic and a predictive biomarker for patients with metastatic osteosarcoma.
    PLOS ONE Staff
    PLoS One; 2017; 12(11):e0188991. PubMed ID: 29186187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction: Metabolomics analysis: Finding out metabolic building blocks.
    Alberich R; Castro JA; Llabrés M; Palmer-Rodríguez P
    PLoS One; 2017; 12(10):e0186626. PubMed ID: 29023538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction: Plasma Metabolomics Biosignature According to HIV Stage of Infection, Pace of Disease Progression, Viremia Level and Immunological Response to Treatment.
    Scarpellini B; Zanoni M; Sucupira MC; Truong HM; Janini LM; da Silva ID; Diaz RS
    PLoS One; 2017; 12(2):e0173164. PubMed ID: 28235085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction: An Empirical Biomarker-Based Calculator for Cystic Index in a Model of Autosomal Recessive Polycystic Kidney Disease-The Nieto-Narayan Formula.
    PLOS ONE Staff
    PLoS One; 2016; 11(12):e0168319. PubMed ID: 27936068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction: Bioassay- and metabolomics-guided screening of bioactive soil actinomycetes from the ancient city of Ihnasia, Egypt.
    Sebak M; Saafan AE; AbdelGhani S; Bakeer W; El-Gendy AO; Espriu LC; Duncan K; Edrada-Ebel R
    PLoS One; 2020; 15(2):e0228901. PubMed ID: 32012209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction: challenges in developing a validated biomarker for angiogenesis inhibitors: the motesanib experience.
    PLOS ONE Staff
    PLoS One; 2015; 10(3):e0121162. PubMed ID: 25811784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction: HP1β is a biomarker for breast cancer prognosis and PARP inhibitor therapy.
    Lee YH; Liu X; Qiu F; O'Connor TR; Yen Y; Ann DK
    PLoS One; 2015; 10(4):e0124853. PubMed ID: 25875848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction: Detection of a Serum Siderophore by LC-MS/ MS as a Potential Biomarker of Invasive Aspergillosis.
    Carroll CS; Amankwa LN; Pinto LJ; Fuller JD; Moore MM
    PLoS One; 2016; 11(5):e0155451. PubMed ID: 27163443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction: Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)?
    Gkika E; Vach W; Adebahr S; Schimek-Jasch T; Brenner A; Brunner TB; Kaier K; Prasse A; Müller-Quernheim J; Grosu AL; Zissel G; Nestle U
    PLoS One; 2018; 13(1):e0192058. PubMed ID: 29370272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction: The Male Fetal Biomarker INSL3 Reveals Substantial Hormone Exchange between Fetuses in Early Pig Gestation.
    Vernunft A; Ivell R; Heng K; Anand-Ivell R
    PLoS One; 2016; 11(6):e0157954. PubMed ID: 27304064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction: Charged metabolite biomarkers of food intake assessed via plasma metabolomics in a population-based observational study in Japan.
    Shibutami E; Ishii R; Harada S; Kurihara A; Kuwabara K; Kato S; Iida M; Akiyama M; Sugiyama D; Hirayama A; Sato A; Amano K; Sugimoto M; Soga T; Tomita M; Takebayashi T
    PLoS One; 2021; 16(4):e0250864. PubMed ID: 33886678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction: Temporal Expression of Peripheral Blood Leukocyte Biomarkers in a Macaca fascicularis Infection Model of Tuberculosis; Comparison with Human Datasets and Analysis with Parametric/Non-parametric Tools for Improved Diagnostic Biomarker Identification.
    Javed S; Marsay L; Wareham A; Lewandowski KS; Williams A; Dennis MJ; Sharpe S; Vipond R; Silman N; Ball G; Kempsell KE
    PLoS One; 2016; 11(7):e0159783. PubMed ID: 27428353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction: Altered Blood Biomarker Profiles in Athletes with a History of Repetitive Head Impacts.
    Di Battista AP; Rhind SG; Richards D; Churchill N; Baker AJ; Hutchison MG
    PLoS One; 2016; 11(10):e0164912. PubMed ID: 27727300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction: Predictive Models of Primary Tropical Forest Structure from Geomorphometric Variables Based on SRTM in the Tapajós Region, Brazilian Amazon.
    PLOS ONE Staff
    PLoS One; 2016; 11(6):e0155569. PubMed ID: 27275746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction: Mapping and predictive variations of soil bacterial richness across France.
    Terrat S; Horrigue W; Dequiedt S; Saby NPA; Lelièvre M; Nowak V; Tripied J; Régnier T; Jolivet C; Arrouays D; Wincker P; Cruaud C; Karimi B; Bispo A; Maron PA; Prévost-Bouré NC; Ranjard L
    PLoS One; 2017; 12(12):e0190128. PubMed ID: 29253898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction: The Patient- And Nutrition-Derived Outcome Risk Assessment Score (PANDORA): Development of a Simple Predictive Risk Score for 30-Day In-Hospital Mortality Based on Demographics, Clinical Observation, and Nutrition.
    PLOS ONE Staff
    PLoS One; 2016; 11(6):e0158023. PubMed ID: 27309731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction: Influence of platinum harmonized textile on neuromuscular, systemic and subjective recovery.
    Zinke F; Bakenecker P; Hahn D
    PLoS One; 2018; 13(1):e0191057. PubMed ID: 29315349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction: Gut dysbiosis is associated with metabolism and systemic inflammation in patients with ischemic stroke.
    Yamashiro K; Tanaka R; Urabe T; Ueno Y; Yamashiro Y; Nomoto K; Takahashi T; Tsuji H; Asahara T; Hattori N
    PLoS One; 2017; 12(4):e0176062. PubMed ID: 28406979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction: evaluating predictive pharmacogenetic signatures of adverse events in colorectal cancer patients treated with fluoropyrimidines.
    Jennings BA; Loke YK; Skinner J; Keane M; Chu GS; Turner R; Epurescu D; Barrett A; Willis G
    PLoS One; 2015; 10(4):e0124893. PubMed ID: 25876069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.